Milan, Italy

Giovanni Buzzi

This inventor holds 2 USPTO granted patents. Top assignees: Pharmacia Ab, Pharmacia Italia S.p.a.. Active years: 1998-2004.


% Patents Active = 100.0

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1998-2004

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Giovanni Buzzi: Innovator in Pharmaceutical Formulations

Introduction

Giovanni Buzzi is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations for parenteral use. With a total of 2 patents, his work has had a meaningful impact on the medical community.

Latest Patents

Buzzi's latest patents include formulations for parenteral use of estramustine phosphate and sulfoalkyl ether cyclodextrins. This innovative pharmaceutical formulation comprises a parenterally acceptable carrier or diluent, estramustine phosphate, and a sulfoalkyl ether cyclodextrin. The formulation can be administered according to a combined chemotherapy regimen in association with one or more chemotherapeutic agents. Notably, this formulation enables estramustine phosphate to be administered with no side effects at the site of injection. Another significant patent involves estramustine formulations with improved pharmaceutical properties.

Career Highlights

Throughout his career, Giovanni Buzzi has worked with prominent companies in the pharmaceutical industry, including Pharmacia Italia S.p.a. and Pharmacia Ab. His expertise in pharmaceutical formulations has positioned him as a valuable asset in the field.

Collaborations

Buzzi has collaborated with several professionals in his field, including Lorena Muggetti and Alessandro Martini. These collaborations have further enhanced his contributions to pharmaceutical innovations.

Conclusion

Giovanni Buzzi's work in pharmaceutical formulations demonstrates his commitment to advancing medical science. His innovative patents and collaborations highlight his role as a key figure in the industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…